{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:28:33Z","timestamp":1791559713043,"version":"4.3.4"},"reference-count":72,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.modpat.2025.100929","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T07:39:14Z","timestamp":1761982754000},"page":"100929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Updates in Peripheral Nerve Sheath and Adipocytic Tumors"],"prefix":"10.1016","volume":"39","author":[{"given":"Sarah","family":"Dry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00401-012-0954-z","article-title":"Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems","volume":"123","author":"Rodriguez","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.modpat.2025.100929_bib2","series-title":"Soft Tissue and Bone Tumors. 5th ed. WHO Classification of Tumours Series","year":"2020"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jmg.36.3.197","article-title":"A clinical study of type 1 neurofibromatosis in north west England","volume":"36","author":"McGaughran","year":"1999","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib5","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/radiol.2503080700","article-title":"Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images","volume":"250","author":"Cai","year":"2009","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.modpat.2025.100929_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1215\/15228517-2008-011","article-title":"Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1","volume":"10","author":"Mautner","year":"2008","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.modpat.2025.100929_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.modpat.2025.100929_bib10","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/jso.23736","article-title":"The effect of surgical margins on outcomes for low grade MPNSTs and atypical neurofibroma","volume":"110","author":"Bernthal","year":"2014","journal-title":"J Surg Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100929_bib11","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00000478-199712000-00006","article-title":"Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors","volume":"21","author":"Lin","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib12","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience","volume":"19","author":"Stucky","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0360-3016(98)00223-5","article-title":"Malignant peripheral nerve sheath tumor: analysis of treatment outcome","volume":"42","author":"Wong","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.modpat.2025.100929_bib14","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/00000478-200310000-00006","article-title":"Malignant peripheral nerve sheath tumor: a comparison of grade, immunophenotype, and cell cycle\/growth activation marker expression in sporadic and neurofibromatosis 1-related lesions","volume":"27","author":"Zhou","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib15","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/neuonc\/noae235","article-title":"Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of neurofibromatosis type 1","volume":"27","author":"Lucas","year":"2025","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100929_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/gcc.20921","article-title":"Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors","volume":"50","author":"Beert","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib17","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/path.2494","article-title":"Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours","volume":"217","author":"Bottillo","year":"2009","journal-title":"J Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2025.100929_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/jnen\/61.8.702","article-title":"Differential NF1, p16, and EGFR patterns by interphase cytogenetics (FISH) in malignant peripheral nerve sheath tumor (MPNST) and morphologically similar spindle cell neoplasms","volume":"61","author":"Perry","year":"2002","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100929_bib19","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/ng.3095","article-title":"PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors","volume":"46","author":"Lee","year":"2014","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.modpat.2025.100929_bib20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/ng.3116","article-title":"Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors","volume":"46","author":"Zhang","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/modpathol.2015.134","article-title":"Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics","volume":"29","author":"Schaefer","year":"2016","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF03401664","article-title":"The CDKN2A (p16) gene and human cancer","volume":"3","author":"Foulkes","year":"1997","journal-title":"Mol Med"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib23","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3171\/2019.7.JNS191353","article-title":"Safe marginal resection of atypical neurofibromas in neurofibromatosis type 1","volume":"133","author":"Nelson","year":"2020","journal-title":"J Neurosurg"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/gcc.23106","article-title":"Malignant peripheral nerve sheath tumor in children: A clinicopathologic and molecular study with parallels to the adult counterpart","volume":"62","author":"Agaram","year":"2023","journal-title":"Genes Chromosomes Cancer"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/PAS.0000000000000589","article-title":"Epithelioid schwannomas: an analysis of 58 cases including atypical variants","volume":"40","author":"Hart","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00000478-200101000-00002","article-title":"Expanding the spectrum of malignant change in schwannomas: epithelioid malignant change, epithelioid malignant peripheral nerve sheath tumor, and epithelioid angiosarcoma: a study of 17 cases","volume":"25","author":"McMenamin","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100929_bib27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/modpathol.2017.91","article-title":"Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions","volume":"30","author":"Le Guellec","year":"2017","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib28","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.prp.2017.12.015","article-title":"Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors","volume":"214","author":"Otsuka","year":"2018","journal-title":"Pathol Res Pract"},{"issue":"12","key":"10.1016\/j.modpat.2025.100929_bib29","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/modpathol.2017.97","article-title":"Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors","volume":"30","author":"Pekmezci","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2025.100929_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2022.151967","article-title":"Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors","volume":"59","author":"Thangaiah","year":"2022","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/CMR.0000000000000648","article-title":"Utility of histone H3K27me3 and H4K20me as diagnostic indicators of melanoma","volume":"30","author":"Davis","year":"2020","journal-title":"Melanoma Res"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41379-018-0140-5","article-title":"H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features","volume":"32","author":"Makise","year":"2019","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00256-022-04171-w","article-title":"Magnetic resonance imaging features and clinical course of malignant melanotic nerve sheath tumors: single institution experience over two decades","volume":"52","author":"Kwok","year":"2023","journal-title":"Skeletal Radiol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib34","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/PAS.0b013e3182a0a150","article-title":"Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of \"melanotic schwannoma\"","volume":"38","author":"Torres-Mora","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2025.100929_bib35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1365-2559.1999.00786.x","article-title":"Spinal melanotic schwannoma: a tumour with poor prognosis","volume":"35","author":"Vallat-Decouvelaere","year":"1999","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.modpat.2025.100929_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/gcc.22254","article-title":"Consistent copy number changes and recurrent PRKAR1A mutations distinguish melanotic schwannomas from melanomas: SNP-array and next generation sequencing analysis","volume":"54","author":"Wang","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00000478-199003000-00002","article-title":"Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome","volume":"14","author":"Carney","year":"1990","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00256-015-2256-8","article-title":"Melanotic schwannoma: an 11-year case series","volume":"45","author":"Khoo","year":"2016","journal-title":"Skeletal Radiol"},{"issue":"17","key":"10.1016\/j.modpat.2025.100929_bib39","first-page":"1451","article-title":"Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma","volume":"118","author":"Zhang","year":"2005","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11912-007-0055-7","article-title":"Unusual histologic and clinical variants of melanoma: implications for therapy","volume":"9","author":"Crowson","year":"2007","journal-title":"Curr Oncol Rep"},{"issue":"8","key":"10.1016\/j.modpat.2025.100929_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100165","article-title":"Undifferentiated and dedifferentiated metastatic melanomas masquerading as soft tissue sarcomas: mutational signature analysis and immunotherapy response","volume":"36","author":"Kasago","year":"2023","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma","volume":"35","author":"Ohsie","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.humpath.2003.09.019","article-title":"HMB-45, S-100, NK1\/C3, and MART-1 in metastatic melanoma","volume":"35","author":"Zubovits","year":"2004","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib44","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.04.007","article-title":"Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature","volume":"78","author":"Kamposioras","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156115","article-title":"Cutaneous melanoma with brain metastasis: report of 193 patients with new observations","volume":"11","author":"Gugger","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0000000000002327","article-title":"Neurofibroma-like desmoplastic melanoma: a series of five cases exploring the role of molecular testing as a diagnostic adjunct and highlighting the differential diagnosis with diffuse-type neurofibroma","volume":"49","author":"Baraban","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2025.100929_bib47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/DAD.0000000000001754","article-title":"Desmoplastic melanomas mimicking neurofibromas","volume":"42","author":"Gerami","year":"2020","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PAS.0000000000000527","article-title":"Metastatic malignant melanoma with complete loss of differentiation markers (undifferentiated\/dedifferentiated melanoma): analysis of 14 patients emphasizing phenotypic plasticity and the value of molecular testing as surrogate diagnostic marker","volume":"40","author":"Agaimy","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/PAS.0000000000001645","article-title":"Dedifferentiated and undifferentiated melanomas: report of 35 new cases with literature review and proposal of diagnostic criteria","volume":"45","author":"Agaimy","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib50","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/cup.13122","article-title":"Metastatic melanoma with dedifferentiation and extensive rhabdomyosarcomatous heterologous component","volume":"45","author":"Campbell","year":"2018","journal-title":"J Cutan Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/his.15309","article-title":"The utility of DNA methylation profiling in the diagnosis of un-, de- and trans-differentiated melanoma: a series of 11 cases","volume":"86","author":"Erdem","year":"2025","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.modpat.2025.100929_bib52","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1038\/s41379-021-00857-z","article-title":"The clinicopathologic spectrum and genomic landscape of de-\/trans-differentiated melanoma","volume":"34","author":"Ferreira","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib53","article-title":"A case of dedifferentiated melanoma with lymph node metastasis where molecular biological tests were useful for diagnosis","volume":"14","author":"Kamata","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.modpat.2025.100929_bib54","article-title":"Skin Tumours","year":"2023","journal-title":"International Agency for Research on Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib55","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1038\/s41467-023-38432-6","article-title":"Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities","volume":"14","author":"Suppiah","year":"2023","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/PAS.0000000000002138","article-title":"Assessment of the utility of the sarcoma DNA methylation classifier in surgical pathology","volume":"48","author":"Miettinen","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib57","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/modpathol.2010.66","volume":"23","author":"Mentzel","year":"2010","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2025.100929_bib58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/PAS.0000000000000936","volume":"41","author":"Creytens","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100929_bib59","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001706","article-title":"Atypical pleomorphic lipomatous tumor: expanding our current understanding in a clinicopathologic analysis of 64 cases","volume":"45","author":"Anderson","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2025.100929_bib60","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/pin.12719","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumor: a clinicopathologic, immunohistochemical, and molecular study of 20 cases","volume":"68","author":"Bahadir","year":"2018","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/his.15474","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumour: a clinicopathologic, immunohistochemical and molecular study of 55 cases, highlighting TP53 gene alterations as a genetic hallmark of atypical pleomorphic lipomatous tumour","volume":"87","author":"Cordier","year":"2025","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.modpat.2025.100929_bib62","first-page":"97","article-title":"Atypical spindle cell lipoma: a clinicopathologic, immunohistochemical, and molecular study emphasizing its relationship to classical spindle cell lipoma","volume":"465","author":"Creytens","year":"2014","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.modpat.2025.100929_bib63","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000770","article-title":"Atypical spindle cell lipomatous tumor: clinicopathologic characterization of 232 cases demonstrating a morphologic spectrum","volume":"41","author":"Marino-Enriquez","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2025.100929_bib64","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1177\/1066896918809189","article-title":"Atypical spindle cell lipomatous tumor with benign heterologous (metaplastic) cartilaginous differentiation","volume":"27","author":"Creytens","year":"2019","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100929_bib65","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/10668969241291881","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumor with hibernoma-like morphology: expanding the morphological spectrum","volume":"33","author":"Cordier","year":"2025","journal-title":"Int J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2025.100929_bib66","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/10668969221098086","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumor with pleomorphic hyalinizing angiectatic tumor-like growth pattern: a search for diagnostic clues","volume":"31","author":"Cordier","year":"2023","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100929_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100454","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumor with sarcomatous transformation: clinicopathologic and molecular analysis of 4 cases","volume":"37","author":"Perret","year":"2024","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100929_bib68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00795-022-00327-8","article-title":"Atypical spindle cell\/pleomorphic lipomatous tumor with a sarcomatous component showing high mitotic activity and Ki-67 labeling index: report of a unique case mimicking dedifferentiated liposarcoma","volume":"55","author":"Sugita","year":"2022","journal-title":"Med Mol Morphol"},{"issue":"4","key":"10.1016\/j.modpat.2025.100929_bib69","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/his.14593","article-title":"Well-differentiated lipomatous neoplasms with p53 alterations: a clinicopathological and molecular study of eight cases with features of atypical pleomorphic lipomatous tumour","volume":"80","author":"Hammer","year":"2022","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.modpat.2025.100929_bib70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ajcp\/aqw137","article-title":"Spindle cell lipomas arising at atypical locations","volume":"146","author":"Ud Din","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100929_bib71","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/PAS.0b013e31829562ed","article-title":"Fibrosarcoma-like lipomatous neoplasm: a reappraisal of so-called spindle cell liposarcoma defining a unique lipomatous tumor unrelated to other liposarcomas","volume":"37","author":"Deyrup","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2025.100929_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100246","article-title":"Lipoblastoma-like tumor and fibrosarcoma-like lipomatous neoplasm represent the same entity: a clinicopathologic and molecular genetic study of 23 cases occurring in both men and women at diverse locations","volume":"36","author":"Gross","year":"2023","journal-title":"Mod Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395225002273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T07:49:23Z","timestamp":1781336963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395225002273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0893395225002273"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100929","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates in Peripheral Nerve Sheath and Adipocytic Tumors","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2025.100929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100929"}}